DWA
ABBV icon

Dorsey Wright & Associates’s AbbVie ABBV Stock Holding History

Dorsey Wright & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,793
Closed -$2.68M – 282
2023
Q1 		$2.68M Sell
16,793
-119
-0.7% -$18.2K 0.81% 67
2022
Q4 		$2.73M Buy
+16,912
New +$2.59M 0.8% 55
2015
Q1 		– Sell
-6,296
Closed -$412K – 105
2014
Q4 		$412K Buy
+6,296
New +$397K 0.19% 77

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dorsey Wright & Associates's ABBV Position: Q2 2023 in Review

Dorsey Wright & Associates sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 16,793 shares — an estimated $2.68M sold.

Dorsey Wright & Associates first reported a position in ABBV in Q4 2014 and held it in 3 quarters. The position peaked at $2.73M in Q4 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Dorsey Wright & Associates reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 16,793 AbbVie shares in Q2 2023, an estimated $2.68M.
  • Dorsey Wright & Associates first reported a position in AbbVie in Q4 2014 and held it in 3 quarters.
  • Dorsey Wright & Associates's AbbVie position peaked at $2.73M in Q4 2022.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Dorsey Wright & Associates's 13F filing for Q2 2023, filed 26 Jul 2023.